Biotech

All Articles

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter revenues report had not been short of major headlines. The compa...

Galapagos stops briefly CAR-T cell treatment trial over Parkinsonism case

.Galapagos has actually stopped briefly registration in a test of a BCMA-directed CAR-T tissue thera...

James Wilson leaving Penn to release two brand-new biotechs

.After much more than thirty years, genetics treatment pioneer James Wilson M.D., Ph.D., is actually...

3 biotechs make an effort to beat the summertime warm by losing personnel

.As biotechs try to turn a fresh web page in August, a minimum of 3 providers have actually lost wor...

venBio elevates $528M for 5th lifestyle sciences VC fund

.Pro venture capital agency venBio has actually raised one more half a billion bucks to acquire biot...

Otsuka pays for $800M for Jnana and also its own clinical-stage PKU drug

.Otsuka Pharmaceutical has actually grabbed Boston-based Jnana Therapies for $800 million so the Eas...

FibroGen lays off 75% of US team as property flunks 2 additional trials

.FibroGen is actually drastically reorganizing its service, laying off 75% of its united state worke...

Tracon relax weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has actually determined to unwind procedures weeks after an injectable immun...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M loss on stopped working epilepsy medicine, touts FDA run

.Our experts actually know that Takeda is hoping to discover a course to the FDA for epilepsy medici...